Señales en vivo de THMO | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies...

Stats
Volumen de hoy	10 786.00
Volumen promedio	72 298.00
Capitalización de mercado	5.52M
EPS	$0 ( 2024-04-04 )
Próxima fecha de ganancias	( $0.0100 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0900
ATR14	$0.00500 (0.72%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Xu Xiaochun	Buy	4 113 158	Common Stock
2024-03-15	Xu Xiaochun	Sell	0	Amendment 4 to 1st Amended & Restated Revolving Credit Agr.
2023-11-17	Xu Xiaochun	Sell	600 000	Common Stock
2023-09-28	Xu Xiaochun	Buy	654 206	Common Stock
2023-09-28	Xu Xiaochun	Sell	0	Amendment 3 to 1st Amended & Restated Revolving Credit Agr.

INSIDER POWER
80.51
Last 97 transactions
Buy: 26 026 445 \| Sell: 10 013 519

Thermogenesis Holdings Correlación

10 Correlaciones Más Positivas
SIEN	0.934
MIST	0.902
MOSY	0.873
SPPI	0.861
BCTG	0.841
NERV	0.837
INM	0.832
USCR	0.815
RMRM	0.811
SUMR	0.809

10 Correlaciones Más Negativas
WLTW	-0.911
HVBC	-0.822
GLAD	-0.815
EVOP	-0.803

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Thermogenesis Holdings Finanzas

Annual	2023
Ingresos:	$9.45M
Beneficio Bruto:	$1.93M (20.44 %)
EPS:	$-7.59

FY	2023
Ingresos:	$9.45M
Beneficio Bruto:	$1.93M (20.44 %)
EPS:	$-7.59

FY	2022
Ingresos:	$10.48M
Beneficio Bruto:	$2.71M (25.85 %)
EPS:	$-20.45

FY	2021
Ingresos:	$9.29M
Beneficio Bruto:	$3.49M (37.58 %)
EPS:	$-43.41

Financial Reports:

No articles found.

Thermogenesis Holdings

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.